Thomas G. Hullinger

1.9k total citations
20 papers, 1.5k citations indexed

About

Thomas G. Hullinger is a scholar working on Molecular Biology, Biomedical Engineering and Rheumatology. According to data from OpenAlex, Thomas G. Hullinger has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Rheumatology. Recurrent topics in Thomas G. Hullinger's work include Bone and Dental Protein Studies (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Thomas G. Hullinger is often cited by papers focused on Bone and Dental Protein Studies (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Thomas G. Hullinger collaborates with scholars based in United States, Indonesia and United Kingdom. Thomas G. Hullinger's co-authors include Hillary M. Semus, Christianna Stack, Brent Dickinson, Rusty L. Montgomery, Joshua M. Lynch, Eva van Rooij, Anita G. Seto, Eric N. Olson, J. Craig Hartman and Ronald J. Shebuski and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Circulation Research.

In The Last Decade

Thomas G. Hullinger

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas G. Hullinger United States	14	988	691	357	159	134	20	1.5k
Marish I.F.J. Oerlemans Netherlands	15	896 0.9×	347 0.5×	346 1.0×	204 1.3×	133 1.0×	60	1.3k
Catherine E. Winbanks Australia	16	1.9k 1.9×	1.0k 1.5×	231 0.6×	197 1.2×	91 0.7×	21	2.5k
Genshan Ma China	19	682 0.7×	309 0.4×	325 0.9×	298 1.9×	77 0.6×	73	1.3k
Melissa Swinnen Belgium	16	600 0.6×	324 0.5×	561 1.6×	217 1.4×	56 0.4×	24	1.2k
Claudio Iaconetti Italy	14	796 0.8×	581 0.8×	314 0.9×	304 1.9×	39 0.3×	19	1.2k
Claudia Bang Germany	13	1.3k 1.3×	1.1k 1.5×	234 0.7×	140 0.9×	34 0.3×	14	1.7k
Stéphanie Simoncini France	15	916 0.9×	397 0.6×	134 0.4×	124 0.8×	56 0.4×	33	1.4k
Lisa E. Dorn United States	15	1.2k 1.2×	612 0.9×	441 1.2×	234 1.5×	46 0.3×	22	1.7k
Ekaterina Klyachko United States	14	737 0.7×	287 0.4×	215 0.6×	237 1.5×	38 0.3×	22	1.2k
Anna Ratajska Poland	25	1.0k 1.0×	223 0.3×	665 1.9×	373 2.3×	121 0.9×	72	1.8k

Countries citing papers authored by Thomas G. Hullinger

Since Specialization

Citations

This map shows the geographic impact of Thomas G. Hullinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Hullinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Hullinger more than expected).

Fields of papers citing papers by Thomas G. Hullinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas G. Hullinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Hullinger. The network helps show where Thomas G. Hullinger may publish in the future.

Co-authorship network of co-authors of Thomas G. Hullinger

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas G. Hullinger. A scholar is included among the top collaborators of Thomas G. Hullinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas G. Hullinger. Thomas G. Hullinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Yujia, David Jaroch, Thomas G. Hullinger, et al.. (2025). Pressure enabled drug delivery (PEDD) of nelitolimod increased therapeutic delivery, reduced immunosuppression, and improved efficacy in porcine and murine liver tumor models. Frontiers in Oncology. 15. 1655794–1655794.

Jaroch, David, et al.. (2024). Intra-arterial Pressure-Enabled Drug Delivery Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model. Journal of Vascular and Interventional Radiology. 35(10). 1525–1533.e4. 4 indexed citations

Jaroch, David, et al.. (2024). Pressure-Enabled Drug Delivery Significantly Increases Intra-Arterial Delivery of Embolic Microspheres to Liver Tumors in a Porcine Model. Journal of Vascular and Interventional Radiology. 36(3). 499–504.e1. 2 indexed citations

Jaroch, David, Chandra C. Ghosh, Prajna Guha, et al.. (2023). Abstract 1858: Enhanced delivery of anti PD-1 antibody to liver tumors in oncopig using pressure enabled drug delivery (PEDD) versus a systemic delivery. Cancer Research. 83(7_Supplement). 1858–1858. 1 indexed citations

Dickinson, Brent, Hillary M. Semus, Rusty L. Montgomery, et al.. (2013). Plasma microRNAs Serve as Biomarkers of Therapeutic Efficacy and Disease Progression in Hypertension-Induced Heart Failure. European Journal of Heart Failure. 15(6). 650–659. 141 indexed citations

Hullinger, Thomas G., Rusty L. Montgomery, Anita G. Seto, et al.. (2011). Inhibition of miR-15 Protects Against Cardiac Ischemic Injury. Circulation Research. 110(1). 71–81. 386 indexed citations

Montgomery, Rusty L., Thomas G. Hullinger, Hillary M. Semus, et al.. (2011). Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure. Circulation. 124(14). 1537–1547. 468 indexed citations

Selig, William M., et al.. (2004). The effect of a novel, dual function histamine H1 receptor antagonist/5-lipoxygenase enzyme inhibitor on in vivo dermal inflammation and extravasation. European Journal of Pharmacology. 506(3). 265–271. 10 indexed citations

Hullinger, Thomas G., et al.. (2004). N‐linked sialyated sugar receptors support haematopoietic cell‐osteoblast adhesions. British Journal of Haematology. 124(4). 534–546. 18 indexed citations

10.

Hullinger, Thomas G., Robert L. Panek, Xiangyang Xu, & Sotirios K. Karathanasis. (2001). p21-activated Kinase-1 (PAK1) Inhibition of the Human Scavenger Receptor Class B, Type I Promoter in Macrophages Is Independent of PAK1 Kinase Activity, but Requires the GTPase-binding Domain. Journal of Biological Chemistry. 276(50). 46807–46814. 14 indexed citations

11.

Hullinger, Thomas G., Quintin Pan, Hema Viswanathan, & Martha J. Somerman. (2001). TGFβ and BMP-2 Activation of the OPN Promoter: Roles of Smad- and Hox-Binding Elements. Experimental Cell Research. 262(1). 69–74. 71 indexed citations

12.

Bunyaratavej, Pintippa, Thomas G. Hullinger, & Martha J. Somerman. (2000). Bone Morphogenetic Proteins Secreted by Breast Cancer Cells Upregulate Bone Sialoprotein Expression in Preosteoblast Cells. Experimental Cell Research. 260(2). 324–333. 24 indexed citations

13.

Hullinger, Thomas G., Russell S. Taichman, Daniel A. Linseman, & Martha J. Somerman. (2000). Secretory products from PC-3 and MCF-7 tumor cell lines upregulate osteopontin in MC3T3-E1 cells. Journal of Cellular Biochemistry. 78(4). 607–616. 23 indexed citations

14.

Somerman, Martha J., Hongjiao Ouyang, Janice E. Berry, et al.. (1999). Evolution of periodontal regeneration: from the roots’ point of view. Journal of Periodontal Research. 34(7). 420–442. 37 indexed citations

15.

Hullinger, Thomas G., et al.. (1998). Effect of bone proteins on human prostate cancer cell lines in vitro. The Prostate. 36(1). 14–22. 24 indexed citations

16.

Mills, C. J., et al.. (1996). Temporal expression of c-fos mRNA following balloon injury in the rat common carotid artery. Cardiovascular Research. 32(5). 954–961. 10 indexed citations

17.

Hartman, J. Craig, et al.. (1994). In vivo validation of a transit-time ultrasonic volume flow meter. Journal of Pharmacological and Toxicological Methods. 31(3). 153–160. 64 indexed citations

18.

Hartman, J. Craig, et al.. (1994). Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat.. Journal of Pharmacology and Experimental Therapeutics. 270(3). 1071–1076. 20 indexed citations

19.

Hartman, J. Craig, Thomas G. Hullinger, Theron M. Wall, & Ronald J. Shebuski. (1993). Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition. European Journal of Pharmacology. 234(2-3). 229–236. 58 indexed citations

20.

Hartman, J. Craig, Theron M. Wall, Thomas G. Hullinger, & Ronald J. Shebuski. (1993). Reduction of Myocardial Infarct Size in Rabbits by Ramiprilat. Journal of Cardiovascular Pharmacology. 21(6). 996–1003. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact